<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04554654</url>
  </required_header>
  <id_info>
    <org_study_id>9995381</org_study_id>
    <nct_id>NCT04554654</nct_id>
  </id_info>
  <brief_title>Progesterone Levels and Endometrial Compaction in Frozen-Thawed Embryo Transfer Cycles</brief_title>
  <official_title>The Correlation of Serum Progesterone Levels With the Degree of Endometrial Compaction on the Day of Frozen Embryo Transfer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cem Demirel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Ataşehir Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to determine whether there is a correlation between endometrial&#xD;
      compaction and serum progesterone levels on the day of frozen embryo transfers by using&#xD;
      transvaginal sonography for the endometrial assessment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is planned to be conducted by prospectively evaluating approximately 200 frozen&#xD;
      embryo transfers within 6 months in a single center. Patients planned to be included in the&#xD;
      study are started estrodiol 6 mg / day on day2-3 of mensturation. 12 days after the start of&#xD;
      estrogen, patients who have endometrial thickness over 7 mm are then started vaginal&#xD;
      progesterone supplementation as per routine practice and are eventually proceeded to embryo&#xD;
      transfer either on day 4 or 6 of progesterone supplementation. In this study investigators&#xD;
      are intended to measure endometrial thickness transvaginally on the day of embryo transfer to&#xD;
      accurately determine the presence of endometrial compaction, assess serum progesterone&#xD;
      levels, evaluate any possible correlations between endometrial compaction, serum progesterone&#xD;
      levels and pregnancy rates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">February 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Months</target_duration>
  <primary_outcome>
    <measure>Ongoing pregnancy rates</measure>
    <time_frame>12 weeks after the last menstrual period of the patient</time_frame>
    <description>Presence of at least one live fetus at the end of the 12th gestational week in patients with endometrial compaction compared to patients without endometrial compaction after frozen embryo transfer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Correlation of Serum Progesterone Levels With the Degree of Endometrial Compaction on the Day of Frozen Embryo Transfer</measure>
    <time_frame>On the day of frozen embryo transfer</time_frame>
    <description>endometrium compacted (became thinner) after the administration of progesterone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>6-7 weeks after the last menstrual period of the patient</time_frame>
    <description>Presence of an intrauterine gestational sac with fetal heart beat at 7th week of gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>5 weeks after the last menstrual period of the patient</time_frame>
    <description>Percentage of gestational sacs compared to the number of embryos transferred</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical miscarriage rate</measure>
    <time_frame>after 5th gestational week</time_frame>
    <description>pregnancy loss after ultrasonographic detection of an intrauterine gestational sac</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Infertility, Female</condition>
  <condition>Infertility of Uterine Origin</condition>
  <condition>Implantation; Placenta</condition>
  <arm_group>
    <arm_group_label>frozen embryo transfer cycles</arm_group_label>
    <description>patients undergoing frozen embryo transfer with artificial hormone replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>transvaginal ultrasound,</intervention_name>
    <description>transvaginal ultrasound performed on day of the start of progesterone supplementation and on the day of frozen embryo transfer; serum progesterone level measurement on day of frozen embryo transfer</description>
    <arm_group_label>frozen embryo transfer cycles</arm_group_label>
    <other_name>serum progesterone level measurement</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women underwent frozen embryo transfer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Woman aged 20-40 years&#xD;
&#xD;
          2. Hormonal(estrogen and progesterone) frozen- thawed embryo transfer cycles&#xD;
&#xD;
          3. Having available blastocyst(s) cryopreserved by vitrification method.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Recurrent implantation failure&#xD;
&#xD;
          2. Recurrent pregnancy loss&#xD;
&#xD;
          3. Presence of uterine pathology&#xD;
&#xD;
          4. Requirement for fresh embryo(s);&#xD;
&#xD;
          5. Presence of any clinically relevant systemic disease contraindicated for assisted&#xD;
             reproduction or pregnancy&#xD;
&#xD;
          6. Allergy history for relevant drugs&#xD;
&#xD;
          7. Body mass index of &lt;18 or &gt;38 kg/m2 at screening&#xD;
&#xD;
          8. Current breastfeeding or pregnancy&#xD;
&#xD;
          9. Refusal or inability to comply with the requirements of the protocol for any reason,&#xD;
             including scheduled clinic visits and laboratory tests&#xD;
&#xD;
         10. Natural or modified natural cycles&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients underwent infertility treatment</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cem Demirel, MD</last_name>
    <phone>+905333229039</phone>
    <email>cemdemirel@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ataşehir Memorial Hospital IVF Department</name>
      <address>
        <city>İstanbul</city>
        <zip>34758</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fırat Tulek, MD</last_name>
      <phone>+905306084874</phone>
      <email>firattulek@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 4, 2020</study_first_submitted>
  <study_first_submitted_qc>September 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2020</study_first_posted>
  <last_update_submitted>January 8, 2021</last_update_submitted>
  <last_update_submitted_qc>January 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Memorial Ataşehir Hospital</investigator_affiliation>
    <investigator_full_name>Cem Demirel</investigator_full_name>
    <investigator_title>professor doctor</investigator_title>
  </responsible_party>
  <keyword>frozen-thawed embryo transfer</keyword>
  <keyword>endometrial compaction</keyword>
  <keyword>progesterone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

